Search Results for 'trial phase'
trial phase published presentations and documents on DocSlides.
Designing Phase I Trials With Targeted Agents:
by giovanna-bartolotta
Challenging Tradition. Chia-Chi (Josh) Lin, MD, P...
Phase I Trial Designs Jud Blatchford, PhD
by faustina-dinatale
Colorado School of Public Health. January 30. th....
Phase II Clinical Trial Austin Goodrich and Laura Peterman
by della
Outline. Review of a phase I trial. What is a phas...
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
by willow
Mary Kay Koenig, MD. Associate Vice Chair for Clin...
HOBIT Hyperbaric Oxygen Brain Injury Treatment Trial: A Multicenter Phase II Adaptive Clinical Trial
by melvin833
B. rain . I. njury . T. reatment Trial: A Multicen...
Phase I and Phase II trial design in
by tatiana-dople
oncology. Shu-Fang Hsu Schmitz. University of Ber...
Price Indexes for Clinical Trial Research: A Feasibility Study
by josiah713
A Feasibility Study. SciSIP. PI Conference, Septe...
Biomarkers in Phase II designs in cancer clinical trials
by conchita-marotz
Methods in Clinical Cancer Research. February 12,...
Trial Design Issues for Phase II Trials
by audrey
Guide to Two-Stage . IIa. Designs and . IIa. /IIb...
Should I Enroll in a Clinical Trial?
by tatyana-admore
David N. Assis, MD. Assistant Professor of Medici...
Therapeutic Agents in Phase III Clinical Trials for Alzheimer’s (Registration Trials)
by sherrill-nordquist
As of 10/2018. Aducanumab: amyloid antibody. Biog...
1 Lecture3 Experiment, trial and survey
by freya
Collecting data. 2. Data . Statistics is a way of ...
What is it like to participate in a clinical trial?
by samir599
Karen-Sue Carlson, MD, PhD. Associate Professor of...
New Prevention Technologies Workshop
by sherrill-nordquist
Module 3: Overview of Prevention Research. www.ic...
How to Find and Participate in a GIST clinical trial
by natalia-silvester
(aka---how to know where to look and who to call)...
What's New in Atopic Dermatitis
by cheryl-pisano
Changing Landscape of Therapeutic Options. Burden...
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
Moving Evidence into Practice: Breast Cancer Highlights From Chicago
by alida-meadow
This program will include a discussion of off-lab...
Peanut Allergy Peanut Allergy Is an Unmet Medical Need
by oneill
The Role of Skin as an . Immune Organ. The Skin: O...
Asking a good early phase clinical trial question
by madeline
NINDS Clinical Trials Methodology COURSE 2019. 1. ...
OV101 Phase 2 “STARS” Clinical Trial
by MoonBabe
. Angelman Society of Israel. November 29th, 2018....
Design considerations for drug development in the era of immuno-oncology
by isabella
Elizabeth Garrett-Mayer, PhD. Director, Division o...
Phase I Trials: Statistical Design Considerations
by marina-yarberry
. Hong Li. (Acknowledgement: some slides from R...
Phase I Trials: Statistical Design Considerations
by natalia-silvester
Phase I Trials: Statistical Design Consideratio...
Santenand ActualEyes start registering patients to participatein Phase
by fauna
The two companies will work diligently toward laun...
How qualitative research contributes to evaluation
by alida-meadow
Professor Alicia . O’Cathain. ScHARR. Universi...
Blinded Sample Size Re-estimation in a Phase III Study Inve
by luanne-stotts
David Morgan (King’s College, London / Consulta...
A phase III trial of adjuvant capecitabine in breast cancer
by myesha-ticknor
(. CREATE-. X/JBCRG. -04. ). C. apecitabine . for...
